Karina Sinding is Corporate Vice President in Product Supply in Novo Nordisk. She has been a member of the Novo Nordisk Pharmatech Board of Directors since 2025 .
Ms. Sinding joined Novo Nordisk in 2004 as an Industrial PhD in Research & Development. In 2009, she moved to CMC Development, and since 2011, she has had several leadership positions within CMC Development and API MDev Process Support. In her current role, she is responsible for support and development of Novo Nordisk´s API production processes.
Ms. Sinding holds a Ph.D in Biochemistry from University of Copenhagen.
Ms. Sinding is a Danish National, born in 1976.
